Bloomberg Podcasts
@bloombergpodcasts·503K subscribers·32.4K videos
Inside the Vaccine Race | Part Seven | Prognosis: Breakthrough
Posted
December 23, 2021
Views
23
Likes
1
Engagement
4.35%
December 23, 2021
23
1
4.35%
Every word spoken in this episode is indexed. Type any phrase to jump straight to the moment it was said.
Type any word or phrase that may have been spoken. Click a result to seek the player to that exact moment.
Try a name, a topic, or a quoted line
35:21Now PlayingTwo biotech companies, Germany’s BioNTech and the U.S.’s Moderna, decided in January 2020 to wager their futures on developing a messenger RNA shot to fight Covid-19. What ensued was a head-spinning race to bring a vaccine to market quicker than ever before.
On Breakthrough, a new series from the Prognosis podcast, we explore how the pandemic is changing our understanding of healthcare and medicine. We start with an examination of long Covid, a mysterious new illness that has stumped doctors attempting to treat symptoms that last for months and potentially years. It has changed the way hospitals work and forced healthcare officials to prepare for the next pandemic. Covid has also opened the door to revolutionary technology: messenger RNA vaccines. It’s a technology that never could have been proven so quickly outside the crucible of that first pandemic year, 2020, and it holds big implications for the future of medicine.
Subscribe to Bloomberg Podcasts
#Bloomberg #Podcasts
Follow Bloomberg Podcasts on Twitter
Visit our other YouTube channels:
Bloomberg Markets & Finance
Bloomberg Politics
Bloomberg Technology
Quicktake Originals
Quicktake Now
Quicktake Explained
For coverage on news, markets and more
Sentinel Indexing in Progress
Metadata and chapters are available. Claim extraction for this episode is pending.
All video content is delivered via YouTube embedded players in accordance with the YouTube Terms of Service. Sentinel provides research tools that promote discovery and accountability across political media.
